Search Results 741-750 of 18476 for Prednisone

1. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

   Chronic oral prednisone or prednisolone therapy for at least 6 continuous months directly preceding Visit 1, and on a stable dose for at least one month prior ...

2. A Study to Test Adding Pembrolizumab to Olaparib Alone as Therapy for Patients with Pancreatic Cancer That Has Spread with Inherited BRCA Mutations - Mayo Clinic

   Patients must not have had a prior diagnosis of immunodeficiency or receiving systemic steroid therapy (defined as ≥ 10 mg prednisone or equivalent) or any ...

3. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

   Immunocompromised patients including patients known to be HIV positive or those on chronic steroids > 20 mg prednisone a day or prednisone-equivalent. Note ...

4. A Study to Compare BAL CD8+ TRM Cells and Lung Fibrosis Scores in COVID-19 Infection Survivors - Mayo Clinic

   Immunocompromised host status due to ongoing therapy with methotrexate, cellcept, azathioprine, prednisone dose > 15 mg daily, rituximab, cyclophosphamide or ...

5. A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis - Mayo Clinic

   Current or previous (within the previous 6 months) use ofDMARDs – prednisone (≥ 10 mg/day), methotrexate,hydroxychloroquine, sulfasalazine, leflunomide ...

6. Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (FRAPPE) - Mayo Clinic

   ... prednisone >10 mg/day or equivalent, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [TNF]-alpha agents) =< 7 days ...

7. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

   ... (prednisone/prednisolone);. Any chronic medical condition requiring a systemic dose of corticosteroid > 10 mg prednisone/prednisolone per day;. History of ...

8. A Study to Evaluate the Safety and Effectiveness of Avapritinib in Patients with Indolent and Smoldering Systemic Mastocytosis - Mayo Clinic

   For patients receiving corticosteroids, the dose must be ≤ 20 mg/d prednisone or equivalent, and the dose must be stable for ≥ 14 days. * 5. Patient must ...

9. Frequent bowel movements - Mayo Clinic

   Mucus in stool: A concern? Pituitary tumors · Prednisone withdrawal: Why taper down slowly?

10. PR3-AAV Resilient Remission or PRRR - Mayo Clinic

    requiring consistently greater than 10 mg of prednisone for disease control which might affect endpoint assessment or, - Other uncontrolled diseases ...